ORION CORPORATION STOCK EXCHANGE RELEASE 28 JULY 2015 at 9.45 a.m. EEST
Orion Corporation's publication schedules for financial reporting in 2016
Orion Corporation will publish its Financial Statement Release 2015 on Tuesday, 2 February 2016.
The publication dates of the Interim Reports in 2016 are as follows:
Interim Report January-March 2016 Wednesday, 27 April 2016
Interim Report January-June 2016 Tuesday, 19 July 2016
Interim Report January-September 2016 Tuesday, 25 October 2016
The Financial Statements and the report of the Board of Directors 2015 will be published on the Company's website at the latest in week 9/2016.
The Annual General Meeting is planned to be held on Tuesday, 22 March 2016 in Helsinki.
Orion's financial reports and related presentation material are available on the Group's website at http://www.orion.fi/investors promptly after the publishing. The website also provides a possibility to register on Orion's mailing lists for releases.
Orion Corporation
| Timo Lappalainen President and CEO | Olli Huotari SVP, Corporate Functions |
Publisher:
Orion Corporation
Communications
Orionintie 1A, FI-02101 Espoo, Finland
Homepage: www.orion.fi
Orion is a globally operating Finnish company developing pharmaceuticals and diagnostic tests - a builder of well-being. Orion develops, manufactures and markets human and veterinary pharmaceuticals, active pharmaceutical ingredients and diagnostic tests. The company is continuously developing new drugs and treatment methods. The core therapy areas of Orion's pharmaceutical R&D are central nervous system (CNS) disorders, oncology and respiratory for which Orion developes inhaled Easyhaler® pulmonary drugs.
Orion's net sales in 2014 amounted to EUR 1,015 million and the Company had about 3,500 employees. Orion's A and B shares are listed on NASDAQ Helsinki.